BamSEC and AlphaSense Join Forces
Learn More

Fate Therapeutics Inc.

NASDAQ: FATE    
Share price (8/15/25): $1.09    
Market cap (8/15/25): $126 million

Plans of Reorganization, Merger, Acquisition or Similar

No filings in this category.